NeuroBo Pharmaceuticals Completes Enrollment Of Part 1 Of Its Phase 2a Clinical Trial Evaluating DA-1241 For Treatment Of MASH
NeuroBo Pharmaceuticals 完成了評估 DA-1241 治療 MASH 的 2a 期臨床試驗第 1 部分的註冊
NeuroBo Pharmaceuticals Completes Enrollment Of Part 1 Of Its Phase 2a Clinical Trial Evaluating DA-1241 For Treatment Of MASH
NeuroBo Pharmaceuticals 完成了評估 DA-1241 治療 MASH 的 2a 期臨床試驗第 1 部分的註冊
使用瀏覽器的分享功能,分享給你的好友吧